COURTNEY SMITH: Open Payments
NPI 1184142226 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 31 payments from 14 companies in 2025. Trend: 2023 $477 · 2024 $1,300 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $166 |
| UCB, Inc. | 4 | $124 |
| GE HEALTHCARE | 4 | $89 |
| Teva Pharmaceuticals USA, Inc. | 3 | $67 |
| Neurocrine BioSciences, Inc. | 2 | $65 |
| Eisai Inc. | 2 | $54 |
| Neurelis, Inc. | 3 | $51 |
| ABBVIE INC. | 2 | $43 |
| Novocure Inc. | 1 | $29 |
| ARGENX US, INC. | 1 | $22 |
Products named: KESIMPTA, Fintepla, AUSTEDO XR, INGREZZA, Leqembi, Zilbrysq, VALTOCO, Optune Gio.
Industry payments across FL — which companies pay providers there.
